NEWTON, MA – Karyopharm Therapeutics Inc. (NASDAQ:KPTI), a pharmaceutical company specializing in the development of treatments for cancer and other major diseases, has announced the approval of ...
Q4 2024 Earnings Call Transcript January 31, 2025 AbbVie Inc. misses on earnings expectations. Reported EPS is $2.16 EPS, expectations were $2.98. Operator: Good morning and thank you for standing by.
Good morning, and thank you for standing by. Welcome to the AbbVie fourth-quarter 2024 earnings conference call. (Operator Instructions) Today's call is also being recorded. If you have any objections ...
Welcome to the OneMain Financial Fourth Quarter 2024 Earnings Conference Call and Webcast. Hosting the call today from OneMain is Peter Poillon, Head of Investor Relations. Today's call is being ...